Smith Brain Trust

A combination of factors including the current corporate tax rate makes pharmaceutical production in the United States more attractive now than investing in either China or India. And adopting advanced technologies such as Continuous Manufacturing (CM) further positions the United States to…

Robinhood’s Nasdaq debut was concerning and lackluster. And to Maryland Smith’s David Kass, it was also familiar.

There’s a growing bipartisan push on Capitol Hill to strengthen antitrust agencies and weaken the dominance a few big companies have over entire industries in the United States, namely the big tech companies. In June, House lawmakers took their first votes on a series of bills that would, for…

Financial institutions should be accounting for climate change, but risk models currently are insufficient for regulators to mandate climate stress testing or capital requirements, Maryland Smith’s Clifford Rossi said this week, speaking to the Subcommittee

What’s ahead for mortgage rates? There will be movement, says Maryland Smith’s Clifford Rossi, the question is: How much?

SMITH BRAIN TRUST – With temperatures rising, Maryland Smith’s David Kass is looking to add a little heat to his biannual list of stocks to watch, dropping four of the picks he made in Decembe

SMITH BRAIN TRUST – In the housing market, 2021 is shaping up to be the year of the bidding war. In the United States, prospective home buyers are facing fierce competition for limited inventory, as low mortgage rates and pent-up demand drives a seller’s market. Homes for sale are seeing multiple…

Maryland Smith’s 18th Annual Recommended Reading for Business Leaders

How the Special Purpose Acquisition Companies went from so hot to, recently, so not.

For the past quarter-century, Italy’s economy has been nearly stagnant – not because of trade shocks, bad government, labor market problems, or lack of technology advancements, but because of a management style that is holding the country back, finds research from Maryland Smith’s Bruno…